Photo by Robert Hood / Fred Hutch
Dr. David Maloney has been appointed the first medical director for cellular immunotherapy at Fred Hutch and the recently opened Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance (SCCA).
Maloney is an immunotherapy researcher and blood cancer physician at Fred Hutch, SCCA and the University of Washington, and holds the Leonard and Norma Klorfine Endowed Chair for Clinical Research at Fred Hutch. In his role as medical director for cellular immunotherapy at the Hutch, Maloney has oversight of critical clinical trials infrastructure and provides expertise for effective research operations. As medical director of the new immunotherapy clinic, Maloney leads the clinic's physicians and oversees research and patient care.
He played a key role in the development of the clinic — the only one of its kind in the nation that's designed to meet the needs of patients participating in immunotherapy clinical trials.
The clinic bears the name of the Bezos family, which has provided catalytic philanthropic gifts and galvanized the community to join them in support of our groundbreaking and lifesaving immunotherapy research.